New Teva Generics
Lapatinib Tablets
- Brand Equivalent:
- Tykerb® Tablets
- Launch Date:
- 12/19/2024
Lisdexamfetamine Dimesylate Capsules CII
- Brand Equivalent:
- Vyvanse® capsules CII
- Launch Date:
- 12/17/2024
Tiopronin Delayed-Release Tablets
- Brand Equivalent:
- Thiola EC® delayed-release tablets
- Launch Date:
- 10/8/2024
Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use
- Brand Equivalent:
- Sandostatin® LAR Depot
- Launch Date:
- 10/1/2024
Naloxone Hydrochloride Nasal Spray (OTC)
- Brand Equivalent:
- Narcan® Nasal Spray
- Launch Date:
- 9/23/2024
Lisdexamfetamine Dimesylate Chewable Tablets CII
- Brand Equivalent:
- Vyvanse® chewable tablets CII
- Launch Date:
- 9/16/2024
Mesalamine Delayed-Release Tablets, USP
- Launch Date:
- 8/22/2024
Paclitaxel Protein-Bound Particles for Injectable Suspension (albumin-bound)
- Brand Equivalent:
- Abraxane® for Injectable Suspension
- Launch Date:
- 7/2/2024
Liraglutide injection
- Brand Equivalent:
- Victoza® injection
- Launch Date:
- 6/24/2024